Biocryst Pharmaceuticals (BCRX) Liabilities and Shareholders Equity: 2010-2015
Historic Liabilities and Shareholders Equity for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Sep 2015 value amounting to $139.0 million.
- Biocryst Pharmaceuticals' Liabilities and Shareholders Equity rose 1.34% to $139.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $555.9 million, marking a year-over-year increase of 49.69%. This contributed to the annual value of $136.9 million for FY2014, which is 180.10% up from last year.
- As of Q3 2015, Biocryst Pharmaceuticals' Liabilities and Shareholders Equity stood at $139.0 million, which was down 7.47% from $150.2 million recorded in Q2 2015.
- In the past 5 years, Biocryst Pharmaceuticals' Liabilities and Shareholders Equity ranged from a high of $150.2 million in Q2 2015 and a low of $39.9 million during Q2 2013.
- In the last 3 years, Biocryst Pharmaceuticals' Liabilities and Shareholders Equity had a median value of $129.9 million in 2015 and averaged $97.0 million.
- Per our database at Business Quant, Biocryst Pharmaceuticals' Liabilities and Shareholders Equity slumped by 47.64% in 2013 and then soared by 255.68% in 2014.
- Biocryst Pharmaceuticals' Liabilities and Shareholders Equity (Quarterly) stood at $82.2 million in 2011, then crashed by 30.13% to $57.4 million in 2012, then dropped by 14.93% to $48.9 million in 2013, then spiked by 180.10% to $136.9 million in 2014, then rose by 1.34% to $139.0 million in 2015.
- Its last three reported values are $139.0 million in Q3 2015, $150.2 million for Q2 2015, and $129.9 million during Q1 2015.